DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1

References

• Choi YJ, Kim N. Gastric cancer and family history. Korean J Intern Med. 2016;31:1042–1053. doi:10.3904/kjim.2016.147.
   PubMed Web of Science ®Google Scholar
• Rahman R, Asombang AW, Ibdah JA. Characteristics of gastric cancer in Asia. World J Gastroenterol. 2014;20:4483–4490. doi:10.3748/wjg.v20.i16.4483.
   PubMed Web of Science ®Google Scholar
• Coccolini F, Montori G, Ceresoli M, Cima S, Valli MC, Nita GE, Heyer A, Catena F, Ansaloni L. Advanced gastric cancer: what we know and what we still have to learn. World J Gastroenterol. 2016;22:1139–1159. doi:10.3748/wjg.v22.i3.1139.
   PubMed Web of Science ®Google Scholar
• Mallardo M, Poltronieri P, D’Urso OF. Non-protein coding RNA biomarkers and differential expression in cancers: a review. J Exp Clin Cancer Res. 2008;27:19. doi:10.1186/1756-9966-27-19.
   PubMed Web of Science ®Google Scholar
• Shen Y, Liu S, Fan J, Jin Y, Tian B, Zheng X, Fu H. Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. EMBO Rep. 2017;18:536–548. doi:10.15252/embr.201643139.
   PubMed Web of Science ®Google Scholar
• She K, Huang J, Zhou H, Huang T, Chen G, He J. lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression. Oncol Rep. 2016;36:2673. doi:10.3892/or.2016.5105.
   PubMed Web of Science ®Google Scholar
• Li J, Chen C, Ma X, Geng G, Liu B, Zhang Y, Zhang S, Zhong F, Liu C, Yin Y, et al. Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation. Nat Commun. 2016;7:11730. doi:10.1038/ncomms11730.
   PubMed Web of Science ®Google Scholar
• She K, Huang J, Zhou H, Huang T, Chen G, He J. LncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression. Oncol Rep. 2016;36:2673–2680. doi:10.3892/or.2016.5105.
   PubMed Web of Science ®Google Scholar
• Ponzio G, Rezzonico R, Bourget I, Allan R, Nottet N, Popa A, Magnone V, Rios G, Mari B, Barbry P. A new long noncoding RNA (lncRNA) is induced in cutaneous squamous cell carcinoma and down-regulates several anticancer and cell differentiation genes in mouse. J Biol Chem. 2017;292:12483–12495. doi:10.1074/jbc.M117.776260.
   PubMed Web of Science ®Google Scholar
• Misawa A, Takayama K-I, Urano T, Inoue S. Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells. J Biol Chem. 2016;291:17861–17880. doi:10.1074/jbc.M116.718536.
   PubMed Web of Science ®Google Scholar
• Luo G, Wang M, Wu X, Tao D, Xiao X, Wang L, Min F, Zeng F, Jiang G. Long non-coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cell Physiol Biochem. 2015;37:2209–2220. doi:10.1159/000438577.
   PubMed Web of Science ®Google Scholar
• Ma DD, Yuan LL, Lin LQ. LncRNA HOTAIR contributes to the tumorigenesis of nasopharyngeal carcinoma via up-regulating FASN. Eur Rev Med Pharmacol Sci. 2017;21:5143–5152. doi:10.26355/eurrev_201711_13831.
   PubMed Web of Science ®Google Scholar
• Guan G-F, Zhang D-J, Wen L-J, Xin D, Liu Y, Yu D-J, Su K, Zhu L, Guo -Y-Y, Wang K. Overexpression of lncRNA H19/miR-675 promotes tumorigenesis in head and neck squamous cell carcinoma. Int J Med Sci. 2016;13:914–922. doi:10.7150/ijms.16571.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang H, Wu X. Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1. Gene. 2019;686:1–7. doi:10.1016/j.gene.2018.10.065.
   PubMed Web of Science ®Google Scholar
• An Y, Chen X-M, Yang Y, Mo F, Jiang Y, Sun D-L, Cai -H-H. LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer. Cancer Cell Int. 2018;18:143. doi:10.1186/s12935-018-0643-7.
   PubMed Web of Science ®Google Scholar
• Li J, Li P, Zhao W, Yang R, Chen S, Bai Y, Dun S, Chen X, Du Y, Wang Y, et al. Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma. Cancer Cell Int. 2015;15:48. doi:10.1186/s12935-015-0201-5.
   PubMed Web of Science ®Google Scholar
• Zeng X, Hu Z, Ke X, Tang H, Wu B, Wei X, Liu Z. Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis. Cell Cycle. 2017;16:2212–2219. doi:10.1080/15384101.2017.1361072.
   PubMed Web of Science ®Google Scholar
• Zhang L, He X, Jin T, Gang L, Jin Z. Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway. Biomed Pharmacother. 2017;96:884–891. doi:10.1016/j.biopha.2017.10.056.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zhang H. Interactions between MAP4K1 and adaptor proteins. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015;40:326–335. doi:10.11817/j.issn.1672-7347.2015.03.015.
   PubMedGoogle Scholar
• Wang Y, Luo H, Li Y, Chen T, Wu S, Yang L. hsa-miR-96 up-regulates MAP4K1 and IRS1 and may function as a promising diagnostic marker in human bladder urothelial carcinomas. Mol Med Rep. 2012;5:260–265. doi:10.3892/mmr.2011.621.
   PubMed Web of Science ®Google Scholar
• Yang H-S, Matthews CP, Clair T, Wang Q, Baker AR, Li -C-CH, Tan T-H, Colburn NH. Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol Cell Biol. 2006;26:1297–1306. doi:10.1128/MCB.26.4.1297-1306.2006.
   PubMed Web of Science ®Google Scholar
• Pereira B, Billaud M, Almeida R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer. 2017;3:506–528. doi:10.1016/j.trecan.2017.05.003.
   PubMed Web of Science ®Google Scholar
• Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfò I, Cassenti A, Piva R, Cassoni P, et al. The RNA-binding protein ESRP1 promotes human colorectal cancer progression. Oncotarget. 2016;8:10007–10024.
   Google Scholar
• Xiong H, Zhao W, Wang J, Seifer BJ, Ye C, Chen Y, Jia Y, Chen C, Shen J, Wang L, et al. Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities. Oncotarget. 2017;8:25721–25735. doi:10.18632/oncotarget.14891.
   PubMedGoogle Scholar
• Dhar SK, Zhang J, Gal J, Xu Y, Miao L, Lynn BC, Zhu H, Kasarskis EJ, St. Clair DK. FUsed in sarcoma is a novel regulator of manganese superoxide dismutase gene transcription. Antioxid Redox Signal. 2014;20:1550–1566. doi:10.1089/ars.2012.4984.
   PubMed Web of Science ®Google Scholar
• Ge Z, Cheng Z, Yang X, Huo X, Wang N, Wang H, Wang C, Gu D, Zhao F, Yao M, et al. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma. Cancer Sci. 2017;108:653–662. doi:10.1111/cas.13200.
   PubMed Web of Science ®Google Scholar
• Bao L, Yuan L, Li P, Bu Q, Guo A, Zhang H, Cui N, Liu B. A FUS-LATS1/2 axis inhibits hepatocellular carcinoma progression via activating hippo pathway. Cell Physiol Biochem. 2018;50:437–451. doi:10.1159/000494155.
   PubMedGoogle Scholar
• Sun H-D, Xu Z-P, Sun Z-Q, Zhu B, Wang Q, Zhou J, Jin H, Zhao A, Tang -W-W, Cao X-F. Down-regulation of circPVRL3 promotes the proliferation and migration of gastric cancer cells. Sci Rep. 2018;8:10111. doi:10.1038/s41598-018-27837-9.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao J, Zhang W, Gan J, Hu C, Huang G, Zhang Y. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci Rep. 2015;5:10159. doi:10.1038/srep10159.
   PubMed Web of Science ®Google Scholar
• Zhou X-J, Wu J, Shi L, Li -X-X, Zhu L, Sun X, Qian J-Y, Wang Y, Wei J-F, Ding Q. PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer. J Exp Clin Cancer Res. 2017;36:149. doi:10.1186/s13046-017-0620-3.
   PubMed Web of Science ®Google Scholar
• Dormann D, Haass C. Fused in sarcoma (FUS): an oncogene goes awry in neurodegeneration. Mol Cell Neurosci. 2013;56:475–486. doi:10.1016/j.mcn.2013.03.006.
   PubMed Web of Science ®Google Scholar
• Brinegar AE, Cooper TA. Roles for RNA-binding proteins in development and disease. Brain Res. 2016;1647:1–8. doi:10.1016/j.brainres.2016.02.050.
   PubMed Web of Science ®Google Scholar
• Han D, Gao X, Wang M, Qiao Y, Xu Y, Yang J, Dong N, He J, Sun Q, Lv G, et al. Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget. 2016;7:22159–22173. doi:10.18632/oncotarget.8063.
   PubMedGoogle Scholar
• Mang Y, Li L, Ran J, Zhang S, Liu J, Li L, Chen Y, Liu J, Gao Y, Ren G. Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells. Onco Targets Ther. 2017;10:1003–1016. doi:10.2147/OTT.S116319.
   PubMed Web of Science ®Google Scholar
• Ward CL, Boggio KJ, Johnson BN, Boyd JB, Douthwright S, Shaffer SA, Landers JE, Glicksman MA, Bosco DA. A loss of FUS/TLS function leads to impaired cellular proliferation. Cell Death Dis. 2014;5:e1572–e. doi:10.1038/cddis.2014.508.
   PubMed Web of Science ®Google Scholar
• Xiong D, Wu Y-B, Jin C, Li -J-J, Gu J, Liao Y-F, Long X, Zhu S-Q, Wu H-B, Xu -J-J, et al. Elevated FUS/TLS expression is negatively associated with E-cadherin expression and prognosis of patients with non-small cell lung cancer. Oncol Lett. 2018;16:1791–1800. doi:10.3892/ol.2018.8816.
   PubMed Web of Science ®Google Scholar
• Ke H, Zhao L, Feng X, Xu H, Zou L, Yang Q, Su X, Peng L, Jiao B. NEAT1 is required for survival of breast cancer cells through FUS and miR-548. Gene Regul Syst Bio. 2016;10:11–17. doi:10.4137/GRSB.S29414.
   PubMed Web of Science ®Google Scholar